{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-030757","form_type":"8-K","ticker":"MBRX","cik":"0001659617","company_name":"Moleculin Biotech, Inc.","filed_at":"2026-09-18T21:00:57+00:00","discovered_at":"2026-09-18T21:02:13.237789+00:00","generated_at":"2026-09-18T21:02:16.446358+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Moleculin Biotech receives Nasdaq delisting notice; bid price below $1 for 30 days","bullets":["Nasdaq notified Moleculin on Sept 15, 2026 that common stock failed minimum bid price ($1) from July 31 to Sept 11, 2026.","Company ineligible for 180-day cure period due to 1-for-25 reverse stock split effected Dec 1, 2025.","Company will request a hearing before Nasdaq Hearings Panel; trading continues pending panel decision.","No assurance of continued listing; risk of suspension or delisting if hearing fails."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-030757","json":"https://secwatch.observer/filing/0001437749-26-030757.json","markdown":"https://secwatch.observer/filing/0001437749-26-030757.md","text":"https://secwatch.observer/filing/0001437749-26-030757.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926030757/0001437749-26-030757-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926030757/mbrx20260914_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-18T21:02:16.446358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}